Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Halil Haldun Emiroglu

Clin Mol Hepatol. 2023;29(3):812-812. Published online May 8, 2023

DOI: https://doi.org/10.3350/cmh.2023.0132

View: 2376 Download: 30

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

Chia-Ming Chu, Yun-Fan Liaw

Clin Mol Hepatol. 2023;29(2):510-512. Published online January 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0018

View: 2991 Download: 76 Web of Science: 1 Crossref: 1

Editorial

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?

Nae-Yun Heo

Clin Mol Hepatol. 2017;23(2):125-127. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0106

View: 7657 Download: 141 Web of Science: 3 Crossref: 3

Original Article

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 7997 Download: 109 Web of Science: 3 Crossref: 4

Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test

Jong Jin Hyun, Yeon Seok Seo, Hyonggin An, Sun Young Yim, Min Ho Seo, Hye Sook Kim, Chang Ha Kim, Ji Hoon Kim, Bora Keum, Yong Sik Kim, Hyung Joon Yim, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu

Clin Mol Hepatol. 2012;18(1):56-62. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.56

View: 7195 Download: 55 Crossref: 9

Editorial

The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection

Tae Yeob Kim

Clin Mol Hepatol. 2012;18(1):29-31. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.29

View: 7680 Download: 34 Crossref: 4

Original Article

Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease

Hyo Jeong Oh, Tae Hyeon Kim, Young Woo Sohn, Yong Sung Kim, Yong Reol Oh, Eun Young Cho, So Yeon Shim, Sae Ron Shin, A Lum Han, Seok Jin Yoon, Haak Cheoul Kim

Clin Mol Hepatol. 2011;17(1):27-36. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.27

View: 10578 Download: 87 Crossref: 54

Editorial

Liver function tests as indicators of metabolic syndrome

Han Chu Lee

Clin Mol Hepatol. 2011;17(1):9-11. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.9

View: 5976 Download: 49 Crossref: 4

1

Transient elastography, true or false?

Yeon Seok Seo

Clin Mol Hepatol. 2009;15(4):431-437. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.431

View: 4148 Download: 26 Crossref: 2

3

The Relationship Between Serum Adiponectin Level and Serum Alanine Aminotransferase Elevation in Korean Male with Nonalcoholic Fatty Liver Disease

Yong Su Lee, M.D., Yong Kyun Cho, M.D., Ji Cheul Pae, M.D., Se Yong Oh, M.D., Mun Su Kang, M.D., Jung Ho Park, M.D., Hong Joo Kim, M.D., Dong Il Park, M.D., Chong Il Sohn, M.D., Woo Kyu Jeon, M.D., Byung Ik Kim, M.D., Won Young Lee, M.D., Ki Won Oh, M.D. Eun Joo Yun, M.D. and Eun Sook Oh, M.D.

Clin Mol Hepatol. 2006;12(2):221-229. Published online January 1, 1970

View: 3000 Download: 24

1 |

Viewed By 6197	MAFLD: How is it different from NAFLD?
Viewed By 5279	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5005	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4169	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 3943	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 225	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 155	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search